Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.

Results for SURPASS-1 and SURPASS-2 trials of tirzepatide in patients with type 2 diabetes inadequately controlled with diet and exercise alone were presented at this year’s virtual symposium. If you weren’t able to attend the symposium, you can read about the trials here. 

A study was conducted to assess if HbA1c variability impacts the incidence of diabetic complications, all-cause and cardiovascular mortality. 

People who reported two or more servings per week of oily fish consumption had a 22% lower risk of developing type 2 diabetes.

Older adults may be at risk of adverse events such as hypoglycemia when overtreated with certain medications. 

After starting SGLT-2i, is the discontinuation of therapy necessary if there is an immediate decline in estimated Glomerular Filtration Rate (eGFR) in patients?

A cohort study evaluated the relationship between the severity of newly diagnosed diabetic retinopathy in adult patients and the incidence of progression to sustained blindness. 

Patients with COVID-19 may be at risk for developing stress-related hyperglycemia, which in turn could increase diabetes risk.

Lowering saturated fats in the diet for Familial Hypercholesterolemia is not supported by randomized controlled trials. 

A century after the discovery of insulin, new insulins, new devices, and other innovations may again change the future of treatment for type 1 diabetes.